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Mitochondrial Metabolism, Dysfunctions in Senescence Cell and 
the Possible Interventions through Herbal Medicines
The mitochondria are the cell`s powerhouse. They are consid-
ered ubiquitous organelles of all eukaryotic cells, being respon-
sible for the cell’s life and death cycle. Through stimuli in the 
environment in which they live, mitochondria can modulate their 
own biogenesis as well as signal retrograde to the nucleus to 
modify the structure of their proteins. Since the mitochondrial 
genome contains only 37 genes, much of the encoding of its pro-
teins depends on the nuclear genome. Thus, the communication 
between mitochondria and the nucleus seems to be a target of 
science in understanding the pathologies associated with this 
organelle. Some medicinal herbs have been shown to influence 
mitochondrial biogenesis, such as Gynostemma pentaphyl-
lun (GP) and berberine, which increase the phosphorylation of 
proteins AMPactivated protein kinase (AMPK). Just as GP and 
berberine phosphorylate AMPK in signaling for mitochondrial 
biogenesis, the sesquiterpene beta-caryophyllene (BCP) demon-
strated positive results in reorganizing mitochondrial transcription 
factors, being an agonist of the peroxisome proliferatoractivated 
alpha receptor (PPAR-α). Another plant derivative, the non-psy-
choactive cannabinoid known as cannabidiol (CBD), has been 
showing control in the metabolism of calcium in the mitochondri-
al matrix. In this review, we seek to get a closer look at the bio-
chemical mechanisms of action of some of these plants, as well 
as their synergies in the results of different treatments. In the 
view of oriental medicines, the use of associated medicinal herbs 
has always been part of their treatment protocols. However, the 
effectiveness of these treatments in relation to plant synergy can 
be observed in future clinical trials for better understanding.
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Introduction  
Mitochondria are considered ubiquitous 
organelles in eukaryotic cells, where they are 
essential for the life cycle and cell death [1]. Its 
structure is formed by two membranes, an 
internal membrane permeable to ions and an 
external membrane permeable to factors <5 kDa 
[2]. In this structure, mainly in the mitochondrial 
matrix, adenosine triphosphate (ATP) is 
generated by oxidative phosphorylation 
(OXPHOS). An electrochemical gradient across 
the inner membrane leads to a proton driving 
force in the intermembrane space that triggers 
ATP synthesis [3]. This process occurs due to 
electrons donated from reduced forms of 
nicotinamide adenine dinucleotide (NADH) and 
flavin adenine dinucleotide (FADH2) generated 
by the oxidation of acetyl-CoA in the tricarboxylic 
acid (TCA) cycle [4]. Under normal conditions, the 
oxidation of certain energy substrates, especially 
fatty acid and glucose-pyruvate, generates 
acetyl CoA in the mitochondrial matrix [4]. 
Electrons from NADH and FADH are transferred 
through the electron transport chain (ETC) 
components in the inner mitochondrial 
membrane. The transfer of electrons along the 
ETC induces the flow of protons through the 
inner membrane reaching the intermembrane 
space. Upon returning to the mitochondrial 
matrix, the protons trigger an enzyme also 
known as ATP synthase, which makes it 





Mitochondrial biogenesis  
Mitochondrial biogenesis is a highly complex 
process [6]. For a better understanding of how 
this whole process works, it is necessary to first 
examine the gene transcription factors involved 
in this mechanism [7]. 
Bearing in mind that the control of activation or 
deactivation of genes comes from signals 
originating from the environment in which cells 
live, such as food intake, thought processing, 
sensitivity to temperature and light intensity, the 
process of signaling mitochondrial biogenesis is 
no different [8]. Upon receiving stimuli such as 
cold and fasting, a protein cAMP response 
element-binding protein (CREB) is 
phosphorylated through another signaling 
protein, protein kinase A (PKA) [9,10]. Once 
phosphorylated, the CREB protein will continue 
the transcription process by phosphorylating the 
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peroxisome proliferator-activated receptor-
gamma coactivator-1alpha (PGC-1α) (Fig. 2) [11]. 
Likewise, there is another metabolic route that 
occurs through physical exercise, where calcium 
binds to two proteins, calmodulin-dependent 
protein kinase IV (CaMKIV) and calcineurin A 
(CnA), which can activate phosphorylation of 
CREB protein, and, consequently, promote 
signaling for peroxisome proliferator-activated 
receptor-gamma coactivator-1alpha (PGC-1α) 
transcription [12]. Once the expression of PGC-
1α is increased, there is a sequence for the 
transcription of specific proteins that interact in 
the process, not only of protein synthesis of the 
respiratory chain, but also of the replication of 
this organelle, among them myocyte 
enhancement factor 2 (MEF-2) [13], nuclear 
respiratory factor 1 and 2 (NRF-1 and NRF-2) [14], 
the estrogen-related alpha receptor (EER-α) [15], 
and also the receptors activated by the 
peroxisome proliferator-activated receptor alpha 
(PPAR-α) [16], the latter being responsible for the 
formation of proteins that carry out beta 
oxidation in mitochondria. A curious fact that 
deserves attention is that MEF-2, like CREB, 
interacts in the PGC-1α transcription process [11]. 
Subsequently, MEF-2 is activated by PGC-1α 
itself, where it will be transferred into the 
mitochondria, triggering the transcription of 
cytochrome c oxidase (Fig. 2) [17]. This path is 
not yet well known to its full extent, but it seems 
that there is a loop between the process in 
activating the transcription of both. 
Another no less important factor about PGC-1α 
signaling is the activation of the AMP-activated 
protein kinase (AMPK) (Fig. 2) [18]. This protein is 
highly expressed in catabolic processes, such as 
physical activity [19]. As a result of a power 
outage, AMPK is strongly phosphorylated, 
increasing it signaling to PGC-1α [20]. Thus, the 
other signaling proteins of the mitochondrial 
biogenesis mentioned above initiate a 
biochemical cascade not only for protein 
synthesis but also for the replication of the 
mitochondrial genome itself, mainly related to 
the respiratory chain [7]. There is also a 
transcription protein synthesized in the 
cytoplasm of cells, called mitochondrial 
transcription factor (TFAM), which plays a 
fundamental role in the maintenance of 
mitochondrial proteins, both in transcription and 
in the replication of this organelle [21]. However, 
not only do these factors interact in maintaining 
the health of mitochondria, but their own genome 
also has a strong interaction for the preservation 
of their structures [22].  
Mitochondrial genome  
The mitochondrial genome, unlike the nuclear 
genome, is circular and has 16,569 DNA base 
pairs, whereas the nuclear genome contains 3.3 
billion DNA base pairs [22,23]. The mitochondrial 
genome is made up of only 37 genes [23]. 
However, in each protein in the respiratory chain, 
there is bilateral participation between the 
nuclear genome together with the mitochondrial 
genome (Fig. 3) [24]. For example, in complex I of 
the respiratory chain, where the entire electron 
flow process begins, 39 genes come from the 
nucleus with only seven coming from 
mitochondria [25]. In complex II, the four genes 
come exclusively from the nucleus, with no 
involvement of the mitochondrial genome in this 
protein [26]. In complex III, ten are nuclear and 
only one mitochondrial [27]. In complex IV, we 
have ten nuclear and three mitochondrial cells 
[28]. In complex V, we have 14 nuclear and two 
mitochondrial [28]. Researchers also claim that 
mitochondrial DNA (mtDNA) is inherited 
exclusively from the female [29]. This is due to the 
presence of mitochondria in the cytoplasm of the 
egg when they are assigned to the zygote, or 
unicellular embryo [30]. In the case of sperm, 
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mitochondria end up being eliminated by 
process of ubiquitination as soon as it enters the 
egg [31]. Once fertilized, this cell will replicate 
mitochondrial DNA only from the mother [29]. 
However, despite the rarity, there have been 
scientific reports of paternal mitochondrial 
inheritance in humans [32]. This fact is due to a 
genetic mutation in the maternal mitochondrial 
DNA itself, which makes it possible to inherit the 




CaMKIV, Calcium/calmodulin-dependent protein kinase IV; CREB, cAMP response element-binding protein; AMPK, 
Adenosine monophosphate kinase; PGC-1α, Peroxisome proliferator-activated receptor-gamma coactivator-1alpha; 
MEF-2, myocyte enhancer factor-2; NRF-1, Nuclear respiratory factor 1; PPAR-α, Peroxisome proliferator-activated 




Mitochondria and Senescent Cells  
Cellular senescence is increasingly recognized 
as the main cause of health loss and physical 
conditioning associated with aging [34]. The 
amount of dysfunctional mitochondria in 
senescent cells is a reality that has been 
reported in several scientific studies, and its 
inefficiency of OXPHO and the increase in 
reactive oxygen species (ROS) trigger serious 
damage to cells [35]. Mitochondrial enzymes 
need to be in perfect working order to synthesize 
ATP in the ideal amounts for cell functioning [36]. 
Any enzymatic change linked to the production 
of energy in these organelles can seriously 
compromise the functioning of tissues [37]. When 
mitochondria are not working well, a wide variety 
of symptoms can arise, including delay or 
regression in physical and mental development 
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[38], impaired language [39], impaired social 
interaction [40], intellectual disability [38,40], 
neuropsychiatric symptoms (ADHD, anxiety, 
OCD, depression) [41], seizures [40], headaches 
[42], hearing problems [40,43], weakness [42], short 
stature [38,42], fatigue [44,45], gastrointestinal 
symptoms [40], endocrine disorders [46], and 
many others. More and more research now 
suggest that mitochondrial dys- function can 
have a major and important influence on several 
health conditions, such as autism [47, 48], bipolar 
disorder [49], schizophrenia [49], depression [50], 
cancer [51, 52], diabetes [53], Parkinson's disease 
[54], asthma [55], chronic fatigue syndrome [44,45], 
Alzheimer's disease [56], gastrointestinal 
disorders [40], nonalcoholic fat liver disease [57] 




In a study on mitochondria in senescent cells, 
the authors Korolchuk et al (2017) demonstrated 
that cell senescence is increasingly recognized 
as the main contributor to health loss and 
especially in decreasing physical conditioning 
associated with aging [58]. Furthermore, it has 
been shown that senescent cells accumulate 
dysfunctional mitochondria, mainly in the 
metabolism of oxidative phosphorylation, 
leading to high production of reactive oxygen 
species [58]. Because cell senescence is part of 
a range of cellular responses to extrinsic and / or 
intrinsic harmful processes that affect 
homeostasis, especially the integrity of both the 
genome and the proteome [59], studies have 
suggested that unregulated mitochondrial fusion, 
fission and mitophagies have been observed in 
cell senescence. These studies have shown 
that,in senescent cells, mitochondrial dynamics 
are strongly reduced [60]. Stress-induced 
premature senescence showed elongated 
mitochondria, with increased crest structure, as 
well as increased mitochondrial content [61]. 
Although studies are already well documented 
about mutations in mtDNA as a cause of 
different types of mitochondrial diseases [62], the 
impact of this mutation as a senescence factor 
has not been well investigated [63]. In the past, 
the first studies excluded the presence of 
deletions or single base changes in mtDNA [64]. 
However, more recently it was demonstrated in 
cell cultures that mtDNA depletion exhibited 
senescent phenotypes, characterizing the 
potential involvement of mtDNA damage in cell 
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senescence [65]. In fact, recent studies support 
the idea that all the nucleus-derived transcription 
factors mentioned above that govern 
mitochondrial biogenesis, PGC-1α, NRF-1/2, 
sirtuins and TFAM are somehow involved in cell 
senescence [63] (Fig 2).  
Retrograde Signaling in Mitochondrial 
Dysfunction 
In mammalian cells, retrograde mitochondrial 
signaling is well understood by the scientific 
community. This process occurs due to an 
altered nuclear expression in response to 
mitochondrial dysfunction with a series of 
signaling pathways involved in this 
communication [66]. From studies on metabolic 
diseases, inflammation and cancer, we have an 
extensive list of important small molecules 
participating in retrograde mitochondrial 
signaling, including ROS, NAD+ / NADH ratio, 
Acetyl-CoA, ATP, Ca2+, and oncometabolite [67]. 
Enzymes such as calcineurin, protein kinase-C 
(PKC), CaMKIV, c-Jun N-terminal kinases (JNK) 
and mitogen activated protein kinase (MAPK), 
as well as the transcription factors activating 
transcription factor 2 (ATF2), CCAAT/enhancer-
binding protein-δ (C/EBP-δ), nuclear factor of 
activated T cells (NFAT), CREB, early growth 
response protein 1 (Egr-1), C/EBP homologous 
protein (CHOP) and nuclear factor kappa-beta 
(NF-κB) participate in the retrograde 
mitochondrial signaling of mammals [68] (Fig. 4). 
Research has reported that, depending on cell 
type and cell conditions, there are essentially 
two branches in the Ca2+ mediated retrograde 
signaling pathway: 1. Ca2+ mediated retrograde 
signaling / calcineurin for nuclear translocation 
of transcription factors, NF- κB, NFAT, CREB 
and heterogeneous nuclear ribonucleoprotein 
A2 (HnRNPA2); and, 2. Direct activation of Ca2+ 
dependent protein kinases, such as those 
previously mentioned, PKC, JNK, MAPK and 
CaMKIV [67]. The activation of these signaling 
pathways in epithelial cells converges in the 
positive regulation of genes that affect several 
cellular functions, including resistance to 
apoptosis and resistance to multiple drugs [69]. 
On the other hand, retrograde signaling is 
triggered by a mitochondrial signal, which, in turn, 
is relayed to one or more protein molecules that 
reach the nucleus. Oncometabolites, for 
example, are metabolites whose abundance is 
significantly increased in cancer cells compared 
to normal cells [70]. Increasing evidence shows 
that oncometabolite and retrograde signaling 
contributes to cancer progression [67,70]. 
Research has already shown the retrograde 
signaling involved in epigenetic changes and 
post-translational protein modifications, 
including proto oncogene c-Src, MAPK, AMPK, 
poly (ADP ribose) polymerase (PARP) and 
sirtuin 1 (SIRT1) in various pathological 
conditions [68, 71, 72].  
Medicinal Herbs  
The plant kingdom has adapted to all habitable 
environments on planet Earth. Because they are 
inanimate beings, the challenges related to 
environmental stress caused several species of 
plants to develop many molecules to avoid 
animal attacks and other environmental 
aggressions [73]. These molecules synthesized 
by plants give the ability to exhale fragrances, 
colors and even toxicity as a protective 
mechanism. [74] Apparently, the discovery of 
medicinal plants by the first humans may have 
been an exercise in trial and error due to the 
need to relieve the manifestations of symptoms, 
such as pain, inflammation and allergic reactions 
to insect bites [75]. In the beginning, before the 
advent of writing, this knowledge was 
transmitted from generation to generation 
through word of mouth. Later, many plants were 
registered as having medicinal properties and 
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were used to treat many diseases [76]. Several 
natural products from plants and animals have 
been the source of medicines, especially for 
anticancer and antimicrobial agents [77, 78]. 
Throughout history, especially in the 20th 
century, traditional medicine has been 
overshadowed by modern medicine as a means 
of treatment for human diseases [79]. However, 
in recent decades, the increase in the use of 
medicinal plants in the treatment of diseases has 
shown remarkable results in many countries, 
including developed countries such as the 
United Kingdom, Germany, France and others 
[80, 81, 82]. In fact, many extracts of medicinal 
plants are being used as prescription drugs with 




mΔΨ, Mitochondrial membrane potential; PKC, Protein Kinase C; CaMKIV, Calcium/calmodulin-dependent protein 
kinase IV; JNK, c-Jun N-terminal kinases; MAPK, mitogen-activated protein kinase; ATF2, Activating Transcription 
Factor 2; CREB, cAMP response element-binding protein; Erg-1, Early growth response protein 1; CEBP-δ, 
CCAAT/enhancer-binding protein delta; CHOP, C/EBP homologous; NFAT, Nuclear factor of activated T-cells protein; 
NF-kβ, Nuclear factor kappa-Beta. 
 
Beta-caryophyllene (BCP), for example, is a 
sesquiterpene found in several types of plants, 
mainly in Cannabis Sativa [84]. This resin has 
remarkable anti-inflammatory properties, as well 
as antitumor activity, including the induction of 
apoptosis by inhibiting B-cell lymphoma 2 (Bcl-2) 
activity [85]. BCP also features the ability to 
rearrange the mitochondrial transcription factors, 
suffering retrograde signaling in this type of 
pathology [86]. Thus, the BCP works as a 
peroxisome proliferator-activated receptor alpha 
(PPAR-α) agonist, one of the most important 
transcription factors in mitochondrial biogenesis 
[87]. Intriguingly, PPAR-α is predominantly 
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present in many cells, including in the liver. 
Previous studies have demonstrated that PPAR-
α plays a critical role in the modulation of energy 
balance and regulation of hepatic lipid through 
mitochondrial metabolism [88]. Another 
mechanism of inflammatory protection exerted 
by BCP is to restore antioxidant enzymes in 
mitochondria, mainly superoxide dismutase 
(SOD), and inhibited lipid peroxidation as well as 
glutathione (GSH) depletion in neurons [89]. 
Similar to the mechanisms of action of BCP, 
beta-caryophyllene oxide (BCPO), due to its 
high biological activity, was extensively studied 
in recent years [90]. Either as a pure substance or 
a component of plant essential oils, BCPO was 
found to exhibit anti-inflammatory, antioxidant, 
antiviral, anticarcinogenic, and analgesic 
properties even better than BCP, mainly in 
anticarcinogenic activity [90, 91]. BCPO induced 
increased ROS generation from mitochondria, 
which is associated with the induction of 
apoptosis as characterized by positive Annexin 
V binding and TUNEL staining, loss of 
mitochondrial membrane potential, the release 
of cytochrome c, activation of caspase-3, and 
cleavage of PARP (Poly (ADP-ribose) 
polymerase) [92]. Proapoptotic activity of BCPO 
in cancer cells can be associated with reduced 
activation of NF‐κβ [90]. NF‐κβ regulates the 
expression of many genes involved in cellular 
proliferation, apoptosis, and inflammation (e.g., 
TRAF—TNF receptor‐associated factor, c‐
FLIP—cellular FLICE‐ like inhibitory protein, 
surviving, various chemokines, and cytokines) 
[93]. Studies reported BCPO‐induced inhibition 
of the constitutive and inducible NF ‐ κβ 
activities in cancer cells. Moreover, they found 
that BCPO increased the tumor necrosis factor α 
(TNF-α) and caused apoptosis by inhibiting the 
NF‐κβ activation [94]. 
Another plant that exerts antitumor activity 
associated with mitochondrial metabolism is 
Artemisia annua [95]. Artemisia annua has been 
described for over two thousand years in 
Traditional Chinese Medicine due to its fever-
reducing capability [96]. In tumor cell artemisinin 
induce apoptosis by increasing metabolism, 
elevated concentration of iron and transferrin, 
and consequently increasing ROS [97]. Studies 
suggested that low doses of artesunate, a 
derivate of Artemisia annua, induced oncosis-
like cell death, characterized by cytoplasmic 
swelling and vacuolization, disorganized 
mitochondria, dilation of the nuclei, and cell lysis 
[98]. However, one of the most tested hypotheses 
about artemisinin, another derivate of Artemisia 
annua, is that the endoperoxide bridge of the 
artemisinin structure reacts with either heme 
groups or intracellular iron, hence producing 
cytotoxic radicals with an alkylating capacity [99, 
100, 101]. The importance of iron in mitochondrial 
function is well known. However, the role of 
mitochondrial iron trafficking in the regulation of 
cellular iron homeostasis is not well understood 
[102]. In mitochondria, iron is used for the 
synthesis of heme and the generation of iron-
sulfur [99]. Thus, linking artemisinin to transport 
into the mitochondria matrix is an interesting 
path [103]. Once inside the mitochondria, 
artemisinin has greater contact with iron, pulling 
an electron from that metal in its endoperoxide 
portion, causing the formation of ROS and 
consequently ferroptosis [104]. Still in relation to 
mitochondrial metabolism, studies related  
that apoptosis of human umbilical vein 
endothelial cells (HUVEC) by artesunate and 
artemisinin is associated with negative 
regulation of Bcl-2 and positive regulation of 
BAX (protein X associated with Bcl-2), the genes 
associated with the control of apoptosis in the 
external mitochondrial membrane [105, 106]. 
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As apoptosis depends on the metabolism of 
calcium, cannabidiol (CBD), present in Cannabis 
sativa, exerts an important mechanism on the 
balance of mitochondrial calcium in the 
mechanism of control of apoptosis [107, 108]. CBD 
is a non-psychoactive plant cannabinoid that 
inhibits cell proliferation and induces cell death 
of breast cancer cells [109]. Studies have shown 
that CBD-mediated cytosolic elevation of free 
Ca2+ has been observed in several cells, 
cancerous and non-cancerous [110], and its 
presence defines the scenarios of cell destiny, 
survival or death [111]. Elevated 
intramitochondrial Ca2+ is a prerequisite for the 
formation of mitochondrial permeability transition 
pore (PTP20), and consequently, apoptosis [112]. 
Usually, the increase in intramitochondrial Ca2+ 
is triggered by an increase in cytosolic Ca2+. In 
most cases, the source of Ca2+ can be via the 
endoplasmic reticulum (ER), whose membrane 
is very close to the external mitochondrial 
membrane (OMM), facilitating the transposition 
of Ca2+ [113]. Thus, CBD interacts directly with 
mitochondrial calcium. Its effect does not 
depend on cannabinoid receptors or Ca2+ 
permeable channels in the plasma membrane. 
Instead, CBD targets the mitochondria directly 
by altering Ca2+ metabolism [109]. In lethal 
concentrations, CBD causes Ca2+ 
mitochondrial overload, the formation of stable 
mitochondrial transition pores and cell death [114]. 
Studies have suggested that CBD is an 
attractive candidate to be included in 
chemotherapy protocols for the treatment of 
acute lymphoblastic leukemia of T lineage (T 
ALL) for its proapoptotic activity in these cell 
types [109]. 
As we can see, mitochondrial metabolism is 
associated with numerous pathologies. Thus, 
controlling mitochondrial biogenesis seems to be 
a promising path for the treatment of several 
diseases [115], mainly when medicinal herbs 
manage to activate the signals of the 
transcription factors involved in mitochondrial 
biogenesis, as in the case of berberine and 
jyagulan (Gynostemma Pentaphyllun) [116, 117].  
Berberine is a natural isoquinoline alkaloid 
derived from the traditional medicinal plant 
Coptis chinensis that has numerous 
pharmacological properties, including 
antimicrobial, antioxidant, anti-inflammatory, 
antidiarrheal, antidiabetic, antilipidemic and 
antitumor activities [116]. Studies have shown 
beneficial effects of berberine in the treatment of 
insulin sensitivity and glucose tolerance due to 
berberine's ability to activate AMPK and 
suppress gluconeogenesis [118, 119]. Berberine 
can also activate SIRT1, a protein that has a two-
way pathway in regulating AMPK [120, 121, 122]. In 
other words, SIRT1 can be regulated by AMPK 
as well as regulating AMPK activity. Thus, 
berberine has been shown to be effective both in 
increasing mitochondrial biogenesis and in 
mitochondrial function in muscle tissue of obese 
rats [120]. 
Following a metabolic pathway like berberine, 
studies have reported that Gynostemma 
pentaphyllun (GP) has also shown remarkable 
properties in AMPK phosphorylation [117]. Since 
AMPK is a key sensor and regulator of glucose, 
lipid and energy metabolism [121], its activation by 
GP improves metabolic abnormalities 
associated with metabolic diseases, including 
obesity and type 2 diabetes [123]. Studies have 
found that GP contains two saponins, also know 
as damulins, which activate AMPK strongly [117]. 
These damulins also act positively in the 
metabolism of β-oxidation and in the uptake of 
glucose by increasing the translocation of GluT4 
to the plasma membrane in L6 myotubular cells 
[117]. A study comparing the effect of GP with a 
control diet and a high-fat diet showed that GP 
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significantly increased SIRT1 mRNA expression, 
as well as AMPK phosphorylation when 
compared to both control groups, and especially 
to the high fat intake group [123]. Several other 
studies have reported that GP can bring 
promising results in the control of metabolic 
syndrome by improving the function of 
mitochondrial metabolism and SIRT1 expression 
[124, 125, 126]. 
Interestingly, SIRT1 is an epigenetic enzyme 
involved in protein deacetylation that acts mainly 
as a metabolic sensor responding to changes in 
the energy state, deacetylation of transcription 
factors and crucial cofactors in cellular 
metabolism [127]. This enzyme also regulates 
several biological functions, including biogenesis, 
inflammation, apoptosis, oxidative stress, 
mitochondrial function and cellular senescence 
[128]. Several studies have shown that resveratrol 
has a good impact on SIRT1 [129, 130]. Resveratrol 
is a naturally occurring polyphenolic component 
that belongs to the class of stilbenes present in 
more than 70 species of plants, mainly in the skin 
of red grapes [131]. Studies have shown that 
resveratrol has inhibitory effects on various 
types of cancer cell lines and preclinical animal 
models in many types of cancer, such as colon, 
breast and lymphoma, due to its activity on 
several subcellular targets, including SIRT1 [132]. 
In fact, resveratrol uses several strategies to 
stimulate apoptosis in cancer therapy. One of 
them is to increase the level of mitochondrial 
oxidative stress, which, in turn, releases 
cytochrome C in the cytosol, activating the 
caspases and triggering apoptosis [133]. It was 
observed that the administration of resveratrol 
triggered a mitochondrial dysfunction due to the 
loss of the mitochondrial membrane potential, 
resulting in the induction of apoptosis in tumor 
cells [134]. Since most cancer cells prefer to use 
glycolysis to generate ATP and simultaneously 
increase their glucose uptake (Warburg effect), 
the antitumor activity shown by resveratrol 
caused, at the same time, a reduction in glucose 
metabolism in cancer cells, as well as the 
induction of mitochondrial breathing in cancer 
therapy [135, 136, 137]. As mentioned  
above, there is a bidirectional interaction 
between the SIRT1 pathway and the AMPK. 
Therefore, it has been reported that the SIRT1 / 
AMPK axis is important in the mitochondrial 
biogenesis, fission, fusion and mitophagy of this 
organelle [138], and resveratrol administration 
had antitumor impacts by affecting mitochondrial 
breathing through positive regulation of SIRT1 
[139]. 
Discussion  
Mitochondria are increasingly in evidence in the 
focus of treatment of various diseases. It is so 
important for cells that recently studies have 
tried to understand the transit of this organelle in 
extracellular spaces. In March 2020, Dache et al. 
published an article with surprised researchers 
since intact mitochondria was found in the 
extracellular space [140]. While several other 
studies have reported the existence of 
extracellular mitochondria under specific 
conditions resulting in platelet activation or 
encapsulated in microvesicles, the authors 
Dache et al. (2020) stated that it is remarkable 
how the presence of mitochondria free of intact 
cells went unnoticed in the normal physiological 
state. Studies have pointed out that intact 
mitochondria free of circulating cells have crucial 
biological and physiological roles, as it was 
scientific knowledge that mitochondria function 
as systemic messengers in cell-cell 
communication through the transfer of hereditary 
and non-hereditary constituents [140, 141]. 
Previous studies also have already reported that 
mitochondria translocate from one cell to 
another. These studies demonstrated that the 
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intercellular mitochondria traffic occurred both in 
vitro and in vivo, and in both physiological and 
pathophysiological conditions, including tissue 
damage and cancer [142, 143]. 
In either of these processes, a transit of 
mitochondria between cells was observed. Patel 
et al. (2017) also demonstrated that 
mitochondria could be internalized by different 
types of cells, such as, for example, 
macropinocytosis, which is a specific endocytic 
pathway for large vesicles [144]. However, 
although clinical mitochondrial transplants 
between cells are an active area of research, the 
specific mechanisms and critical factors involved 
in the natural transfer of mitochondria between 






Numerous studies have been looking for 
therapies on how to preserve mitochondrial 
structures, especially in mtDNA, with the 
administration of drugs, herbal medicines and 
nutraceutical products [125, 139]. In both cases, 
such as importing healthy mitochondria into 
dysfunctional tissues, as well as administering 
phytochemicals to rescue the integrity of the 
mitochondria in dysfunctional tissue, research 
has shown to be increasingly favorable to the 
treatment of mitochondria in relation to 
associated diseases. The many herbs reported 
in this present study had medicinal properties 
aimed directly and/or indirectly at mitochondria 
in various diseases. This makes us reflect on 
how influential mitochondria are in diseases as 
well as in aging. Another hypothesis that could 
be answered in future clinical trials would be how 
much the retrograde mitochondrial signaling 
would be related to the cause of diseases such 
as cancer, for example. What science has 
known until now is that the membrane 
morphology of these organelles undergoes 
radical changes in diseases such as Alzheimer's 
disease, Parkinson's, non-alcoholic liver 
cirrhosis and cancer itself [146]. Rescuing the 
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anterograde signals, that is, from the nucleus to 
the mitochondria under normal conditions, could 
be a hypothesis to help reverse diseases 
associated with mitochondria. Once retrograde 
signaling is activated because of chronic stress, 
altering the expressions of certain genes that 
would modify mitochondrial structures is a fact. 
Administering herbal medicines and specific 
coenzymes that act in the respiratory chain 
seems to be an interesting way of controlling 
oxidative stress and reversing retrograde 
signaling processes [86, 110, 115, 116, 117, 134].  
Another factor to be observed would be a 
possible administration of plants synergistically 
in the control of mitochondrial apoptosis. For 
example, piperlungumine, the biologically active 
compound from the Piper longum plant, when it 
is administered, a reduction in reduced 
glutathione levels is observed in cancer cells by 
inhibiting the enzyme glutathione reductase (GR) 
[147]. This would be fantastic if this type of cell did 
not defend itself by increasing the expression of 
nuclear factor erythroid 2-related factor 2 (Nfr-2). 
With the increase in Nfr-2, cancer cells can 
produce more antioxidants counterbalancing the 
reduction of glutathione by piperlungumin 
protect itself [148, 149]. However, the use of luteolin, 
a flavonoid found in several plants, can inhibit of 
Nfr-2 activity in cancer cells [150]. Therefore, the 
effects of piperlungumine in controlling 
mitochondrial glutathione levels are likely to be a 
promising path in herbal therapies when used in 
synergy with another herb such as luteolin. In the 
same way that drugs must be administered 
together to treat certain diseases, medicinal 
plants also follow the same reasoning.  
Conclusion  
Pathologies directly or indirectly related to 
mitochondria have been the target of studies in 
several types of diseases. Since enzymatic 
changes in mitochondrial metabolism, as well as 
changes in the genome of this organelle are 
decisive factors in disease control, the scientific 
community is increasingly committed to 
understanding not only the functioning of 
mitochondria but mainly why this imbalance in its 
metabolism occurs in diseases. A classic 
example of this is the retrograde signaling 
between the mitochondria and the cell nucleus, 
as related above. Likewise, changes both 
environmental and emotional, as well as 
inadequate food intake, can cause a series of 
changes in the structures of mitochondria, 
especially in the transcription factors that 
modulate mitochondrial genome. Therefore, 
understanding how to control mitochondrial 
imbalance in the fight against pathologies is a 
necessary tool to be applied, especially when we 
talk about medicinal herbs which have the 
capacity to control the proteins involved in 
mitochondrial biogenesis (AMPK, PPARs e etc.). 
However, future studies will be needed to 
evaluate the results of medicinal herbs, 
especially when they are administered 
concomitantly, as well as in Traditional Chinese 
Medicine and Ayurvedic Medicine, and not just 
alone. Some studies have already shown that 
the synergy between medicinal herbs can really 
bring benefits in different treatments, but no 
clinical study has yet been proposed to treat 
mitochondrial diseases to date. As mitochondrial 
changes are extensive in several diseases, the 
proposal to administer different medicinal herbs 
that act in different areas of mitochondrial 
metabolism seems to be an interesting path from 
the biochemical point of view to be investigated.  
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